Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes (original) (raw)

Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions

Mark Paine

British Journal of Pharmacology, 2009

View PDFchevron_right

Modeling Chemical Interaction Profiles: I. Spectral Data-Activity Relationship and Structure-Activity Relationship Models for Inhibitors and Non-inhibitors of Cytochrome P450 CYP3A4 and CYP2D6 Isozymes

Richard Beger

Molecules, 2012

View PDFchevron_right

Computational Prediction of Inhibitors and Inducers of the Major Isoforms of Cytochrome P450

Vladimir Poroikov

Molecules

View PDFchevron_right

In Silico Prediction of Drug–Drug Interactions Mediated by Cytochrome P450 Isoforms

Vladimir Poroikov

Pharmaceutics

View PDFchevron_right

Computational modeling of P450s for toxicity prediction

Nitish Kumar Mishra

Expert Opinion on Drug Metabolism & Toxicology, 2011

View PDFchevron_right

Mechanism-based inhibition of cytochrome P450 enzymes: An evaluation of early decision making in vitro approaches and drug–drug interaction prediction methods

Ken Grime

European Journal of Pharmaceutical Sciences, 2009

View PDFchevron_right

A Novel Approach to Predicting P450 Mediated Drug Metabolism. CYP2D6 Catalyzed N-Dealkylation Reactions and Qualitative Metabolite Predictions Using a Combined Protein and Pharmacophore Model for CYP2D6

Alexander istia Alex

Journal of Medicinal Chemistry, 1999

View PDFchevron_right

A unified proteochemometric model for prediction of inhibition of cytochrome P450 isoforms

Ola Spjuth

View PDFchevron_right

Cytochromes P450 and experimental models of drug metabolism

Eva Anzenbacherova

Journal of Cellular and Molecular Medicine, 2002

View PDFchevron_right

Minireview PHARMACOPHORE AND THREE-DIMENSIONAL QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP METHODS FOR MODELING CYTOCHROME P450 ACTIVE SITES

Archbald Chakalila

View PDFchevron_right

In-silico endogenic substrate prediction study of Cytochrome P450 1B1 (CYP1B1)

Rahul Vishvkarma

2019

View PDFchevron_right

Modeling Chemical Interaction Profiles: II. Molecular Docking, Spectral Data-Activity Relationship, and Structure-Activity Relationship Models for Potent and Weak Inhibitors of Cytochrome P450 CYP3A4 Isozyme

Richard Beger

Molecules, 2012

View PDFchevron_right

The Utility of in Vitro Cytochrome P450 Inhibition Data in the Prediction of Drug-Drug Interactions

Larry Tremaine

Journal of Pharmacology and Experimental Therapeutics, 2005

View PDFchevron_right

A Novel Model for the Prediction of Drug-Drug Interactions in Humans Based on in Vitro Cytochrome P450 Phenotypic Data

Lisa von Moltke

Drug Metabolism and Disposition, 2006

View PDFchevron_right

A Mechanism-Based Model for the Prediction of the Metabolic Sites of Steroids Mediated by Cytochrome P450 3A4

jiayue wang

International Journal of Molecular Sciences, 2015

View PDFchevron_right

A Kinetic Model for the Metabolic Interaction of Two Substrates at the Active Site of Cytochrome P450 3A4

Thomas Rushmore

Journal of Biological Chemistry, 2001

View PDFchevron_right

Cytochromes P450 in the Bioactivation of Chemicals

Costas Ioannides

Current Topics in Medicinal Chemistry, 2004

View PDFchevron_right

Discerning Relationships Among Human Cytochrome P450s by Computational Analyses

Rajeev Soni, Kulvinder Saini

View PDFchevron_right

In vitro cytochrome P450 inhibition data and the prediction of drug-drug interactions: qualitative relationships, quantitative predictions, and the rank-order approach

Larry Tremaine

Clinical pharmacology and therapeutics, 2005

View PDFchevron_right

2D SMARTCyp Reactivity-Based Site of Metabolism Prediction for Major Drug-Metabolizing Cytochrome P450 Enzymes

Gregory Tawa

Journal of Chemical Information and Modeling, 2012

View PDFchevron_right

Integrated in Vitro Analysis for the in Vivo Prediction of Cytochrome P450-Mediated Drug-Drug Interactions

James Tucker

Drug Metabolism and Disposition, 2008

View PDFchevron_right

Heterologous expression of CYP102A5 variant from Bacillus cereus CYPPB-1: Validation of model for predicting drug metabolism of human P450 probe substrates

prakasham Reddy shetty

View PDFchevron_right

Prediction of cytochrome P 450 isoform responsible for metabolizing a drug molecule

Gajendra P S Raghava

BMC pharmacology, 2010

View PDFchevron_right

SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions

Stefan Guenther, Robert Preissner

Nucleic Acids Research, 2010

View PDFchevron_right

Murburn precepts for cytochrome P450 mediated drug/xenobiotic metabolism

Abhinav Parashar

2020

View PDFchevron_right

Do Cytochrome P450 Enzymes Contribute to the Metabolism of Xenobiotics in Human?

Sampo Mattila

intechopen.com

View PDFchevron_right

The role of polymorphic cytochrome P450 enzymes in drug design, development and drug interactions with a special emphasis on phenotyping

Emel Arinc

J Mol Catal B Enzym, 2010

View PDFchevron_right

Extension of a predictive substrate model for human cytochrome P4502D6

Célia Fonseca Guerra

1997

View PDFchevron_right

Cytochromes P450 and metabolism of xenobiotics

Eva Anzenbacherova

Cellular and Molecular Life …, 2001

View PDFchevron_right

Integrated structure- and ligand-based in silico approach to predict inhibition of cytochrome P450 2D6

philippe vayer

Bioinformatics (Oxford, England), 2015

View PDFchevron_right

Molecular modeling of mammalian cytochrome P450s

Fred Friedman

2000

View PDFchevron_right

A Refined 3-Dimensional QSAR of Cytochrome P450 2C9: Computational Predictions of Drug Interactions

Ron Aoyama, Sreedhara Voleti

View PDFchevron_right